Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Oncol. Dec 24, 2020; 11(12): 1018-1028
Published online Dec 24, 2020. doi: 10.5306/wjco.v11.i12.1018
Table 1 Baseline characteristics of breast cancer patients
Variables
Levels
Total, n %
Agemean ± SD48.28 ± 11.83
RegionPunjab88 (88.0%)
Khyber Pakhtunkhwa7.0 (7.0%)
Kashmir3.0 (3.0%)
Sindh2.0 (2.0%)
HistologyDuctal91 (91.0%)
Others9.0 (9.0%)
GradeII35 (35.0%)
III56 (56.0%)
UNK09 (9.0%)
Tumor sizeT17.0 (7.0%)
T2/T357 (57.0%)
UNK36 (36.0%)
NodesNegative37 (37.0%)
Positive50 (50.0%)
UNK13 (13.0%)
MetastasisNegative38 (38.0%)
Positive49 (49.0%)
UNK13 (13.0%)
Estrogen receptorNegative69 (69.0%)
Positive31 (31.0%)
Progesterone receptorNegative74 (74.0%)
Positive26 (26.0%)
HER2 statusNegative74 (74.0%)
Positive26 (26.0%)
TNBCNo51 (51.0%)
Yes49 (49.0%)
StatusAlive50 (50.0%)
Death35 (35.0%)
Lost to follow-up15 (15.0%)
FOXP3Negative75 (75.0%)
Positive25 (25.0%)
IDO scoreLow24 (24.0%)
Medium27 (27.0%)
High49 (49.0%)
Table 2 Comparative characteristics of triple negative breast cancer and hormone positive breast cancer patients
Variables
Levels
Triple negative breast cancer, n (%)
Hormone positive breast cancer, n (%)
Agemean ± SD47.24 ± 11.549.27 ± 12.0
HistologyDuctal46 (50.5)45 (49.5)
Others3 (33.3)6 (66.7)
Total49 (49.0)51 (51.0)
GradeII9 (25.7)26 (74.3)
III37 (66.1)19 (33.9)
UNK3 (33.3)6 (66.7)
Total49 (49.0)51 (51.0)
Tumor sizeT14 (57.1)3 (42.9)
T2/T326 (45.6)31 (54.4)
UNK19 (52.8)17 (47.2)
Total49 (49.0)51 (51.0)
NodesNegative23 (62.1)14 (37.8)
Positive21 (42.0)29 (58.0)
UNK5 (38.4)8 (61.6)
Total49 (49.0)51 (51.0)
MetastasisNegative23 (60.5)15 (39.5)
Positive21 (42.8)28 (57.2)
UNK5 (38.4)8 (61.6)
Total49 (49.0)51 (51.0)
Table 3 Clinicopathological characteristics of breast cancer patients with nuclear forkhead box P3 expression
Case
Histology
Age in yr
Grade
Nodes
Metastasis
ER
PR
HER2
TNBC
1Ductal2830----+
2Ductal54314+---+
3Ductal6731+---+
4Ductal652UNKUNK---+
5Ductal45313+---+
6Ductal4530----+
7Ductal5530----+
8Ductal2330----+
9Ductal4720----+
10Ductal7332+---+
11Ductal3530----+
12Ductal3530----+
13Ductal523UNKUNK---+
14Ductal3930----+
15Ductal4830----+
16Ductal7032+---+
17Ductal40313+---+
18Ductal35313+---+
19Ductal4330UNK--+-
20Ductal3621+--+-
21Ductal453UNKUNK++--
22Ductal7126++---
23Ductal30217+++--
24Ductal402UNKUNK--+-
25Ductal6220-+++-
Table 4 Patients and tumor characteristics of forkhead box P3 negative vs positive
Variables
Characteristics
FOXP3 negative 75 (75.0%)
FOXP3 positive 25 (25.0%)
P value
Age (yr)mean ± SD48.60 ± 11.0247.32 ± 14.200.64
IDO scoreLow22 (91.7%)2 (8.3%)0.01a
Medium23 (85.2%)4 (14.8%)
High30 (61.2%)19 (38.8%)
GradeII28 (80.0%)7 (20.0%)0.21
III38 (67.9%)18 (32.1%)
MetastasisNegative27 (71.1%)11 (28.9%)0.45
Positive39 (79.6%)10 (20.4%)
Tumor sizeT14 (57.1%)3 (42.9%)0.15
T2/T346 (80.7%)11 (19.3%)
Lymph nodes involvementNegative26 (70.3%)11 (29.7%)0.29
Positive40 (80.0%)10 (20.0%)
Estrogen receptor Negative48 (69.6%)21 (30.4%)0.06
Positive27 (87.1%)4 (12.9%)
Progesterone receptorNegative52 (70.3%)22 (29.7%)0.06
Positive23 (88.5%)3 (11.5%)
HER2–neu receptorNegative53 (71.6%)21 (28.4%)0.19
Positive22 (84.6%)4 (15.4%)
Triple negative breast cancerNo44 (86.3%)7 (13.7%)0.01a
Yes31 (63.3%)18 (36.7%)
Table 5 Univariable and multivariable logistic regression analysis for forkhead box P3-negative (reference) vs forkhead box P3-positive
Variables
Characteristics
Univariable analysis odds ratio (95%CI), P value
Multivariable analysis odds ratio (95%CI), P value
IDO scoreLow Ref.Ref.
Medium1.91 (0.32-11.52), 0.502.32 (0.37-14.50), 0.37
High6.97 (1.50-33.10), 0.01a5.90 (1.22-28.64), 0.03a
Triple negative breast cancerNoRef.Ref.
Yes3.65 (1.36-9.80), 0.01a2.80 (0.96-7.95), 0.05a